Patents by Inventor Jan Mikkelsen
Jan Mikkelsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20070123696Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.Type: ApplicationFiled: August 3, 2006Publication date: May 31, 2007Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20070010660Abstract: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.Type: ApplicationFiled: August 10, 2006Publication date: January 11, 2007Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20070004904Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.Type: ApplicationFiled: August 3, 2006Publication date: January 4, 2007Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060286068Abstract: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.Type: ApplicationFiled: August 10, 2006Publication date: December 21, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060286069Abstract: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.Type: ApplicationFiled: August 10, 2006Publication date: December 21, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060275257Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g., be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g., be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate has one or more improved properties such as increased biological half-life and reduced side effects.Type: ApplicationFiled: August 2, 2006Publication date: December 7, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060270829Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.Type: ApplicationFiled: August 3, 2006Publication date: November 30, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060270703Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.Type: ApplicationFiled: August 3, 2006Publication date: November 30, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20060084793Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g., be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g., be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate has one or more improved properties such as increased biological half-life and reduced side effects.Type: ApplicationFiled: August 3, 2005Publication date: April 20, 2006Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20050147587Abstract: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.Type: ApplicationFiled: February 8, 2005Publication date: July 7, 2005Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20050095684Abstract: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.Type: ApplicationFiled: December 3, 2004Publication date: May 5, 2005Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
-
Publication number: 20010042055Abstract: A parcel self-servicing machine for check-in and/or delivery of items, such as mail items, library books, postal order items etc. Is capable of communicating via a global computer network. Items to be checked in or delivered may be pre-announced via the global computer network. The system may be adapted to receive payment, e.g. credit card payment. May have an item receiving unit having a cylinder shell part defining an interior cavity, the shell part having an opening defined therein for allowing items to pass between the exterior and the interior of the shell part. The system may comprise at least two storage parts for storing items and a connecting part for connecting a chosen storage part and a receiving/delivery platform. A plurality of storage parts may be arranged on a carrousel. Maintenance may be performed on the system by means of an electronic connection between an electronic service tool and the control unit of the system.Type: ApplicationFiled: February 7, 2001Publication date: November 15, 2001Inventors: Jan Didriksen, Jorn Vagn Hundeboll, Wolmer Jorgensen, John Nymann Pedersen, Jan Mikkelsen, Leif Fleming Rasmussen
-
Patent number: 4995469Abstract: A mounting arrangement which facilitates the positioning of an operator's station on the frame of a work vehicle at a plurality of elevationally spaced apart positions relative to a longitudinal axis of the work vehicle and permits control of the operation of the work vehicle from each of the first and second positions is provided. The mounting arrangement includes first and second elevationally spaced apart frames for supporting the operator's station at the first and second spaced apart locations, respectively. A connecting device connects the operator's station to the first and second frames. A controllable component which is mounted on the vehicle frame is adapted to vary operation of a function of the vehicle. The controllable component is connected to a selecting device mounted on the operator's station by a directing device which passes a control signal from the selecting device to the controllable component. The mounting arrangement is particularly suited for use on a material handling vehicle.Type: GrantFiled: September 25, 1989Date of Patent: February 26, 1991Assignee: Caterpillar Industrial Inc.Inventors: Jan Mikkelsen, Kjell Sorlie
-
Patent number: 4896748Abstract: A full free lift mast assembly having a first pair of spaced apart uprights, a second pair of spaced apart uprights mounted on the first pair of uprights and elevationally movable therealong and a carriage mounted on the second pair of uprights is provided. A first mast lift jack is connected between the first and second pairs of spaced apart uprights, and first and second interconnected carriage lift jacks are pivotally connected to and between the second pair of spaced apart uprights and the carriage. A first connecting arrangement connects a cylinder of the first and second carriage lift jacks and maintains the first and second carriage lift jacks parallel, in a preselected overlapping relationship relative to each other. Therefore, bending of the carriage lift jacks, fluid leakage, missequencing and the like have been substantially reduced. The full free lift mast assembly is particularly suited for use on a material handling vehicle.Type: GrantFiled: May 27, 1988Date of Patent: January 30, 1990Assignee: Caterpillar Industrial Inc.Inventors: Jan Mikkelsen, Kjell Sorlie
-
Patent number: 4491195Abstract: The invention relates to an adjustable mounting arrangement (10) for a rotatable guide member (12) of a lift mast assembly (14) which eliminates the problems of inadvertent loosening, complexity of adjustment and premature wear. The mounting arrangement (10) includes a shaft (36) having an eccentric portion (42) upon which the rotatable guide member (12) is mounted. A cam member (78) is connected to a first end portion (38) of the shaft (36) and engageable by a mating member (86) which retains the shaft (36), at one of a plurality of incrementally rotational positions of the cam member (78) from rotational and axial movement. The mounting arrangement (10) is particularly useful in lift chain guide and side thrust roller applications.Type: GrantFiled: November 9, 1982Date of Patent: January 1, 1985Assignee: Towmotor CorporationInventors: Jan Mikkelsen, Kjell Sorlie